Patient-derived glioma cells were characterized by immunofluorescence using Nestin, a neural progenitor marker, SOX2, a marker for pluripotency and self-renewal, and astrocytic marker GFAP confirms cells of glial origin in the culture (Fig. 1b). The gene discussed is SOX2; the disease is glioma.